While the Chicago Diabetes Project (CDP) has thus far only performed islet cell transplants on a smaller subset of type 1 patients in clinical trials, their ultimate goal is to one day offer the transplant for everyone with diabetes—including type 2s. Jose Oberholzer, MD, explains . . .
It’s the early afternoon on the Calmette Campus in Lille. In a small room on the second floor of a building, two technicians are busy extracting DNA from blood samples from diabetes patients. Downstairs, automated instruments are sequencing genes from the patients’ cells at a furious pace.
The Chicago Diabetes Project is working to make islet cell transplantation a viable treatment option for diabetes. Based in Chicago at the University of Illinois Hospital & Health Sciences System, the Chicago Diabetes Project is a collection of scientists, researchers, physicians and surgeons . . .